108 related articles for article (PubMed ID: 19835150)
1. [Metabolic characteristics of GS-nS0 myeloma cells producing anti-CD25 monoclonal antibody in serum-free culture].
Zhao L; Fan L; Zhang X; Tan W
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1069-76. PubMed ID: 19835150
[TBL] [Abstract][Full Text] [Related]
2. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
Spens E; Häggström L
Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
[TBL] [Abstract][Full Text] [Related]
3. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
[TBL] [Abstract][Full Text] [Related]
4. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
[TBL] [Abstract][Full Text] [Related]
5. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
6. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC
Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.
Barnes LM; Bentley CM; Moy N; Dickson AJ
Biotechnol Bioeng; 2007 Feb; 96(2):337-48. PubMed ID: 17001634
[TBL] [Abstract][Full Text] [Related]
8. Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions.
Ho Y; Varley J; Mantalaris A
Biotechnol Prog; 2006; 22(6):1560-9. PubMed ID: 17137302
[TBL] [Abstract][Full Text] [Related]
9. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
Wu MH; Dimopoulos G; Mantalaris A; Varley J
Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
[TBL] [Abstract][Full Text] [Related]
10. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
Browne SM; Al-Rubeai M
Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
[TBL] [Abstract][Full Text] [Related]
11. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
[TBL] [Abstract][Full Text] [Related]
12. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
Gramer MJ; Maas J
Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
Krampe B; Swiderek H; Al-Rubeai M
Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
[TBL] [Abstract][Full Text] [Related]
14. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
[TBL] [Abstract][Full Text] [Related]
15. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
Tey BT; Al-Rubeai M
Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
[TBL] [Abstract][Full Text] [Related]
16. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis.
Veraitch FS; Al-Rubeai M
Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848
[TBL] [Abstract][Full Text] [Related]
17. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
Ozturk SS; Palsson BO
Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
[TBL] [Abstract][Full Text] [Related]
18. High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler.
Choo CY; Tian Y; Kim WS; Blatter E; Conary J; Brady CP
Biotechnol Prog; 2007; 23(1):225-31. PubMed ID: 17269692
[TBL] [Abstract][Full Text] [Related]
19. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
20. NS0 cell damage by high gas velocity sparging in protein-free and cholesterol-free cultures.
Zhu Y; Cuenca JV; Zhou W; Varma A
Biotechnol Bioeng; 2008 Nov; 101(4):751-60. PubMed ID: 18814288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
